1. Home
  2. SEPN vs BALY Comparison

SEPN vs BALY Comparison

Compare SEPN & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • BALY
  • Stock Information
  • Founded
  • SEPN 2022
  • BALY 2004
  • Country
  • SEPN United States
  • BALY United States
  • Employees
  • SEPN N/A
  • BALY 10000
  • Industry
  • SEPN
  • BALY Hotels/Resorts
  • Sector
  • SEPN
  • BALY Consumer Discretionary
  • Exchange
  • SEPN NYSE
  • BALY Nasdaq
  • Market Cap
  • SEPN 631.0M
  • BALY 737.4M
  • IPO Year
  • SEPN 2024
  • BALY N/A
  • Fundamental
  • Price
  • SEPN $5.90
  • BALY $18.04
  • Analyst Decision
  • SEPN Buy
  • BALY Hold
  • Analyst Count
  • SEPN 4
  • BALY 7
  • Target Price
  • SEPN $33.00
  • BALY $18.00
  • AVG Volume (30 Days)
  • SEPN 257.0K
  • BALY 363.4K
  • Earning Date
  • SEPN 05-15-2025
  • BALY 02-19-2025
  • Dividend Yield
  • SEPN N/A
  • BALY N/A
  • EPS Growth
  • SEPN N/A
  • BALY N/A
  • EPS
  • SEPN N/A
  • BALY N/A
  • Revenue
  • SEPN $1,075,000.00
  • BALY $2,481,783,000.00
  • Revenue This Year
  • SEPN N/A
  • BALY $3.06
  • Revenue Next Year
  • SEPN N/A
  • BALY N/A
  • P/E Ratio
  • SEPN N/A
  • BALY N/A
  • Revenue Growth
  • SEPN 611.92
  • BALY 2.80
  • 52 Week Low
  • SEPN $4.17
  • BALY $9.74
  • 52 Week High
  • SEPN $28.99
  • BALY $18.38
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • BALY 60.77
  • Support Level
  • SEPN N/A
  • BALY $14.67
  • Resistance Level
  • SEPN N/A
  • BALY $15.79
  • Average True Range (ATR)
  • SEPN 0.00
  • BALY 2.04
  • MACD
  • SEPN 0.00
  • BALY 0.58
  • Stochastic Oscillator
  • SEPN 0.00
  • BALY 97.51

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About BALY Bally's Corporation

Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.

Share on Social Networks: